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Introduction {#embr201949752-sec-0001}
============

Cardiac metabolism is essential to produce adenosine triphosphate (ATP), which is required for cardiac homeostasis and function (Neely & Morgan, [1974](#embr201949752-bib-0053){ref-type="ref"}; Kolwicz *et al*, [2013](#embr201949752-bib-0034){ref-type="ref"}). During development, embryonic cardiomyocytes (CMs) mainly utilize glucose metabolism for ATP production (Piquereau & Ventura‐Clapier, [2018](#embr201949752-bib-0057){ref-type="ref"}). As the heart grows, CMs exhibit metabolic changes and rely mostly on fatty acid oxidation (Cho *et al*, [2006](#embr201949752-bib-0007){ref-type="ref"}; Chung *et al*, [2007](#embr201949752-bib-0009){ref-type="ref"}, [2010](#embr201949752-bib-0010){ref-type="ref"}; Kreipke *et al*, [2016](#embr201949752-bib-0037){ref-type="ref"}). It has also been shown that under conditions of cardiac disease, such as ischemia and heart failure, CMs revert to glucose as an energy source (Das *et al*, [1987](#embr201949752-bib-0014){ref-type="ref"}; Doenst *et al*, [2013](#embr201949752-bib-0017){ref-type="ref"}).

Unlike adult mammals, adult zebrafish regenerate their heart effectively after injury (Poss *et al*, [2002](#embr201949752-bib-0058){ref-type="ref"}). During cardiac regeneration, CMs re‐express *hand2* (Schindler *et al*, [2014](#embr201949752-bib-0064){ref-type="ref"}), a transcription factor gene required for cardiac development, as well as an embryonic myosin (Sallin *et al*, [2015](#embr201949752-bib-0063){ref-type="ref"}), and they also exhibit sarcomere disassembly (Jopling *et al*, [2010](#embr201949752-bib-0029){ref-type="ref"}; Ben‐Yair *et al*, [2019](#embr201949752-bib-0005){ref-type="ref"}; Beisaw *et al*, [2020](#embr201949752-bib-0004){ref-type="ref"}). These and other studies (Kikuchi *et al*, [2010](#embr201949752-bib-0030){ref-type="ref"}; Wu *et al*, [2016](#embr201949752-bib-0072){ref-type="ref"}; Grajevskaja *et al*, [2018](#embr201949752-bib-0023){ref-type="ref"}) suggest that in zebrafish, CMs undergo dedifferentiation to supply new CMs during cardiac regeneration. Thus, CMs may utilize similar regulatory mechanisms during development and regeneration, yet the role of cardiac metabolism in these processes remains unclear.

Pyruvate dehydrogenase kinase plays an essential role in pyruvate metabolism (Gudi *et al*, [1995](#embr201949752-bib-0024){ref-type="ref"}; Takubo *et al*, [2013](#embr201949752-bib-0068){ref-type="ref"}; Zhang *et al*, [2014](#embr201949752-bib-0074){ref-type="ref"}). Glucose is initially converted to pyruvate through several glycolytic intermediates, and then, pyruvate is converted to lactate via anaerobic fermentation (Lehninger *et al*, [2005](#embr201949752-bib-0041){ref-type="ref"}), or to acetyl‐coenzyme A (acetyl‐CoA) by the PDC (Behal *et al*, [1993](#embr201949752-bib-0003){ref-type="ref"}). By inhibiting the conversion of pyruvate to acetyl‐CoA, PDK induces the conversion of pyruvate to lactate, via anaerobic fermentation (Korotchkina & Patel, [2001](#embr201949752-bib-0035){ref-type="ref"}; Koukourakis *et al*, [2005](#embr201949752-bib-0036){ref-type="ref"}). These studies indicate that PDK regulates the shift of pyruvate metabolism between glycolysis and OXPHOS (Korotchkina & Patel, [2001](#embr201949752-bib-0035){ref-type="ref"}; Koukourakis *et al*, [2005](#embr201949752-bib-0036){ref-type="ref"}; Takubo *et al*, [2013](#embr201949752-bib-0068){ref-type="ref"}; Park *et al*, [2018](#embr201949752-bib-0054){ref-type="ref"}). Higher expression of PDKs in cancer and stem cells, which rely mainly on glycolysis, has been associated with their enhanced proliferation and migration (Takubo *et al*, [2013](#embr201949752-bib-0068){ref-type="ref"}; Zhang *et al*, [2014](#embr201949752-bib-0074){ref-type="ref"}; Park *et al*, [2018](#embr201949752-bib-0054){ref-type="ref"}).

Here, we first show that glycolytic enzymes are upregulated at the transcriptional level during cardiac regeneration. Pharmacological and genetic manipulations as well as CM‐specific modulation of glycolytic activity reveal its importance in CM proliferation after injury. We also found that modulation of pyruvate metabolism can affect mammalian CM cell cycle progression and cell behavior. Transcriptomic analyses show that PDK3 overexpression (OE) leads to higher levels of genes encoding cell cycle regulators in CMs. These data indicate that metabolism plays an important role in CM proliferation following cardiac injury.

Results and Discussion {#embr201949752-sec-0002}
======================

Glycolysis and pyruvate metabolism modulate cardiomyocyte dedifferentiation and proliferation following cardiac injury {#embr201949752-sec-0003}
----------------------------------------------------------------------------------------------------------------------

Adult mammalian CMs rely mainly on fatty acid oxidation as a source of energy (Cho *et al*, [2006](#embr201949752-bib-0007){ref-type="ref"}; Chung *et al*, [2007](#embr201949752-bib-0009){ref-type="ref"}, [2010](#embr201949752-bib-0010){ref-type="ref"}; Kreipke *et al*, [2016](#embr201949752-bib-0037){ref-type="ref"}). We started by performing proteomic analysis and found higher levels of fatty acid oxidation enzymes in adult zebrafish ventricles compared to those in juveniles (Fig [1](#embr201949752-fig-0001){ref-type="fig"}A and B). These findings are consistent with mammalian models, in which adult CMs express higher levels of fatty acid oxidation enzymes (Puente *et al*, [2014](#embr201949752-bib-0059){ref-type="ref"}; Fukushima *et al*, [2019](#embr201949752-bib-0100){ref-type="ref"}).

![Glycolysis and pyruvate metabolism play an important role following cardiac injury\
A30 and 150 days post fertilization (dpf) zebrafish ventricles were isolated and relative protein levels determined (*n* = 3 biological replicates).BKEGG over‐representation analysis for selected categories of upregulated proteins in 150 dpf hearts compared to 30 dpf hearts.CqPCR analysis of mRNA levels of glycolytic enzyme genes in 5 dpci remote and wound border cardiac tissue (*n* = 2--3 technical replicates using pooled cDNA from 10 ventricles for each condition (*n* = 2 for *pkmb* and *pdk4*, and *n* = 3 for the other genes)).D, EImmunostaining of heart sections for PCNA and MEF2 (D) or N2.261 and MEF2 (E) in 5 dpci animals treated with PBS, 2‐DG, or DCA; magnified view of area in white boxes shown below; white dashed lines outline the wound area; arrowheads point to PCNA ^+^ (D) or N2.261^+^ (E) CMs; percentage of PCNA ^+^ or N2.261^+^ CMs in the border zone shown on the right (*n* = 4--5 ventricles).Data information: Error bars, s.e.m.; *P* values were calculated by Bayesian‐moderated *t*‐test (limma) (A, B), two‐tailed unpaired *t*‐test (C), or ordinary one‐way ANOVA with Dunnett\'s multiple comparison test (D, E). Scale bars, 50 μm.](EMBR-21-e49752-g002){#embr201949752-fig-0001}

It has been suggested that zebrafish CMs utilize similar regulatory mechanisms during cardiac development and regeneration (Poss *et al*, [2002](#embr201949752-bib-0058){ref-type="ref"}; Jopling *et al*, [2010](#embr201949752-bib-0029){ref-type="ref"}; Kikuchi *et al*, [2010](#embr201949752-bib-0030){ref-type="ref"}; Wu *et al*, [2016](#embr201949752-bib-0072){ref-type="ref"}). We have recently shown that glycolysis plays an important role during zebrafish cardiac development (Fukuda *et al*, [2019](#embr201949752-bib-0020){ref-type="ref"}). Thus, we wanted to examine whether the expression levels of glycolytic enzyme genes were changed in zebrafish ventricles after cryoinjury. We found significant upregulation of many of them in the tissues bordering the damaged area when compared to remote areas (Fig [1](#embr201949752-fig-0001){ref-type="fig"}C). This finding is supported by a single‐cell RNA‐sequencing analysis in regenerating zebrafish hearts (Honkoop *et al*, [2019](#embr201949752-bib-0027){ref-type="ref"}). Notably, we found high upregulation of *pdk2b*,*pdk3b,* and *pdk4* (Fig [1](#embr201949752-fig-0001){ref-type="fig"}C), which encode key enzymes that regulate pyruvate metabolism and promote glycolysis in a number of cell types including CMs (Zhao *et al*, [2008](#embr201949752-bib-0075){ref-type="ref"}) and cancer cells (Koukourakis *et al*, [2005](#embr201949752-bib-0036){ref-type="ref"}; Leclerc *et al*, [2017](#embr201949752-bib-0038){ref-type="ref"}; Peng *et al*, [2018](#embr201949752-bib-0055){ref-type="ref"}). We also measured lactate levels, which are indicative of glycolytic activity, and found higher levels in regenerating cardiac tissues (Fig [EV1](#embr201949752-fig-0001ev){ref-type="fig"}A). These and other observations (Honkoop *et al*, [2019](#embr201949752-bib-0027){ref-type="ref"}) suggest that adult zebrafish CMs switch from fatty acid oxidation to glycolytic metabolism in response to cardiac injury. In order to examine the role of glycolysis and Pdk function following cardiac injury, we treated zebrafish with 2‐deoxy‐D‐glucose (2‐DG) and dichloroacetate (DCA), which decrease glycolysis and Pdk function, respectively. Notably, these treatments led to a decrease in CM proliferation in the border zone following injury (Figs [1](#embr201949752-fig-0001){ref-type="fig"}D and [EV1](#embr201949752-fig-0001ev){ref-type="fig"}B). We also found that the re‐expression of embryonic myosin, which has been reported to indicate CM dedifferentiation during cardiac regeneration (Sallin *et al*, [2015](#embr201949752-bib-0063){ref-type="ref"}), was reduced when glycolysis or Pdk function was decreased (Fig [1](#embr201949752-fig-0001){ref-type="fig"}E). These data suggest that glycolysis and pyruvate metabolism as regulated by Pdk play a role in border zone CMs following cardiac injury.

![Relative quantification of selected proteins from mass spectrometry data\
Lactate levels were measured in 5 dpci wound border cardiac tissue after treatment with PBS, 2‐DG, or DCA compared to uninjured (*n* = 3 biological replicates, each consisting of tissue from 10 ventricles).Staining of heart sections for phospho histone‐3 (pHH3), MF20, and DNA (DAPI) in 5 dpci animals after treatment with PBS, 2‐DG, or DCA; magnified view of area in white boxes shown in the top right corner; arrowhead points to pHH3^+^ CMs; white dashed lines outline the wound area; percentage of pHH3^+^ CMs in the border zone shown on the right (*n* = 4--5 ventricles).Data information: Error bars, s.e.m.; *P* values were calculated by ordinary one‐way ANOVA with Dunnett\'s multiple comparison test. Scale bars, 25 μm.](EMBR-21-e49752-g003){#embr201949752-fig-0001ev}

Genetic manipulation of metabolic enzymes affects cardiomyocyte dedifferentiation and proliferation following cardiac injury {#embr201949752-sec-0004}
----------------------------------------------------------------------------------------------------------------------------

Next, we assessed whether the loss of specific metabolic enzymes affected CM behavior after cardiac injury. We first examined the role of Pkm2. Mammalian *Pkm* gives rise to two splice isoforms, *Pkm1* and *Pkm2*; PKM2 promotes glucose metabolism toward lactate, while PKM1 promotes glucose metabolism toward acetyl‐CoA (Lehninger *et al*, [2005](#embr201949752-bib-0041){ref-type="ref"}; Christofk *et al*, [2008](#embr201949752-bib-0008){ref-type="ref"}). Knockdown of *PKM2* has been reported to lead to decreased glycolytic activity in human umbilical vein endothelial cells (Stone *et al*, [2018](#embr201949752-bib-0066){ref-type="ref"}) and intestinal stem cells (Kim *et al*, [2019](#embr201949752-bib-0031){ref-type="ref"}), as well as upregulation of PKM1 (Lunt *et al*, [2015](#embr201949752-bib-0047){ref-type="ref"}; Zheng *et al*, [2016](#embr201949752-bib-0076){ref-type="ref"}). Similarly, *Pkm2* OE in mouse CMs leads to enhanced glycolysis (Magadum *et al*, [2020](#embr201949752-bib-0049){ref-type="ref"}). The zebrafish genome contains two *pkm* genes (*pkma* and *pkmb*), with *pkma* encoding both an orthologue of mammalian *Pkm1* (*pkma1*) and an orthologue of mammalian *Pkm2* (*pkma2*), while *pkmb* encodes another orthologue of mammalian *Pkm2* (Stone *et al*, [2018](#embr201949752-bib-0066){ref-type="ref"}). Expression analysis in adult ventricles indicates that *pkma* is upregulated in tissues bordering the injured area, while *pkmb* is not (Fig [1](#embr201949752-fig-0001){ref-type="fig"}C), suggesting a role for *pkma* following cardiac injury. In *pkma2* mutant zebrafish, the *pkma1* isoform, which promotes glucose metabolism toward acetyl‐CoA, remains intact, suggesting that the metabolism of pyruvate to lactate is impaired while pyruvate oxidation is increased. These data indicate that a zebrafish *pkma2* mutant constitutes a potential model of impaired glycolysis, as pyruvate is expected to be converted preferentially to acetyl‐CoA and not lactate. Thus, we examined *pkma2* ^−/−^; *pkmb* ^+/−^ animals, which do not display obvious cardiac defects compared to WT (Fig [EV2](#embr201949752-fig-0002ev){ref-type="fig"}A--C), and found that they exhibited a reduction in the number of proliferating CMs after cardiac injury (Figs [2](#embr201949752-fig-0002){ref-type="fig"}A and [EV2](#embr201949752-fig-0002ev){ref-type="fig"}D). Consistently, the expression of embryonic myosin was also decreased in *pkma2* ^−/−^; *pkmb* ^+/−^ animals (Fig [2](#embr201949752-fig-0002){ref-type="fig"}B). We also examined *pkma2* ^−/−^ animals and found that they exhibit a similar decrease in PCNA^+^ and N2.261^+^ CMs following cardiac injury (Figs [EV2](#embr201949752-fig-0002ev){ref-type="fig"}E and F). Together, these results suggest that reducing glycolysis by affecting Pkma2 function leads to an attenuation in CM dedifferentiation and proliferation during regeneration.

![Loss of *pkma* or *ppargc1a* does not lead to obvious alterations in heart size or embryonic myosin expression in uninjured hearts\
A, BStaining of heart sections for MF20, DNA (DAPI), and phalloidin (A) or MEF2, DNA (DAPI), and N2.261 (B) in uninjured WT, *pkma2* ^−/−^; *pkmb* ^+/−^, and *ppargc1a* ^−/−^ animals; magnified view of area in white boxes shown on the right.CPercentage of heart weight to body weight in adult WT, *pkma2* ^−/−^; *pkmb* ^+/−^, and *ppargc1a* ^−/−^ animals (*n* = 7 animals of each genotype).DStaining of heart sections for pHH3, MF20, and DNA (DAPI) in 5 dpci *pkma2* ^+/−^; *pkmb* ^+/−^ and *pkma2* ^−/−^; *pkmb* ^+/−^ animals; magnified view of area in white boxes shown in the top right corner; arrowheads point to pHH3^+^ CMs; white dashed lines outline the wound area; percentage of pHH3^+^ CMs in the border zone shown on the right (*n* = 4--5 ventricles of each genotype).E, FImmunostaining of heart sections for PCNA and MEF2 (E) or N2.261 and MEF2 (F) in 5 dpci *pkma2* ^+/−^ and *pkma2* ^−/−^ animals; magnified view of area in white boxes shown in the top right corner; arrowheads point to PCNA^+^ (E) or N2.261^+^ (F) CMs; white dashed lines outline the wound area; percentage of PCNA^+^ or N2.261^+^ CMs in the border zone shown on the right (*n* = 3 ventricles of each genotype).GStaining of heart sections for pHH3, MF20, and DNA (DAPI) in 5 dpci *ppargc1a* ^+/+^, *ppargc1a* ^−/−^ animals; magnified view of area in white boxes shown in the top right corner; arrowheads point to pHH3^+^ CMs; white dashed lines outline the wound area; percentage of pHH3^+^ CMs in the border zone shown on the right (*n* = 4--5 ventricles of each genotype).HqPCR analysis of *ppargc1a*,*atp5pf*, and *ndufb5* mRNA levels in 5 dpci remote and wound border heart tissues (*n* = 3 technical replicates using pooled cDNA from 10 ventricles for each condition).Data information: Error bars, s.e.m.; *P* values were calculated by ordinary one‐way ANOVA with Dunnett\'s multiple comparison test (C) or two‐tailed unpaired *t*‐test (D--H). Scale bars, 50 μm in (A, B); 25 μm in (D--G).](EMBR-21-e49752-g005){#embr201949752-fig-0002ev}

![Loss of *pkma2* and *ppargc1a* affects cardiomyocyte dedifferentiation and proliferation following cardiac injury\
A--DImmunostaining of heart sections for PCNA and MEF2 (A, C) or N2.261 and MEF2 (B, D) in 5 dpci *pkma2* ^+/−^; *pkmb* ^+/−^ and *pkma2* ^−/−^; *pkmb* ^+/−^ (A, B) or *ppargc1a* ^+/+^ and *ppargc1a* ^−/−^ (C, D) animals; magnified view of area in white boxes shown below; arrowheads point to PCNA ^+^ (A, C) or N2.261^+^ (B, D) CMs; white dashed lines outline the wound area; percentage of PCNA ^+^ (A, C) or N2.261^+^ (B, D) CMs in the border zone shown on the right (*n* = 4--6 ventricles of each genotype).E, FAFOG staining of heart sections from 60 dpci *pkma2* ^+/−^; *pkmb* ^+/−^ and *pkma2* ^−/−^; *pkmb* ^+/−^ (E) or 45 dpci *ppargc1a* ^+/+^ and *ppargc1a* ^−/−^ (F) animals; black dashed lines outline the scar area; scar area measured on the right (*n* = 3--5 ventricles of each genotype).Data information: Error bars, s.e.m.; *P* values were calculated by two‐tailed unpaired *t*‐test. Scale bars, 50 μm.](EMBR-21-e49752-g004){#embr201949752-fig-0002}

Conversely, in order to determine whether enhanced glycolytic activity can promote cardiac regeneration, we examined the role of *peroxisome proliferator‐activated receptor gamma coactivator 1 alpha* (*ppargc1a*), which encodes a key regulator of mitochondrial oxidative metabolism (Lin *et al*, [2005](#embr201949752-bib-0044){ref-type="ref"}). Forced *Ppargc1a* expression in CMs enhances oxygen consumption and mitochondrial respiration *in vitro* and *in vivo* (Lehman *et al*, [2000](#embr201949752-bib-0039){ref-type="ref"}), while *Ppargc1a*‐deficient mice exhibit decreased oxygen consumption in their left ventricular tissues (Lehman *et al*, [2008](#embr201949752-bib-0040){ref-type="ref"}). Zebrafish *ppargc1a* mutant hearts exhibit reduced mitochondrial oxidative metabolism and increased glycolytic activity (Marin‐Juez *et al*, [2019](#embr201949752-bib-0050){ref-type="ref"}) without obvious cardiac defects (Fig [EV2](#embr201949752-fig-0002ev){ref-type="fig"}A--C). Altogether, these data suggest that in *ppargc1a* mutant hearts, pyruvate oxidation is reduced while metabolism of pyruvate to lactate is increased, and thus, *ppargc1a* mutants constitute a potential model of increased glycolysis. First, we examined the mRNA expression levels of *ppargc1a* and its targets *atp5pf* and *ndufb5* and found that these genes were down‐regulated in the cardiac tissues bordering the damaged area at 5 dpci (Fig [EV2](#embr201949752-fig-0002ev){ref-type="fig"}H). Notably, *ppargc1a* mutants exhibited an increase in proliferating CMs (Figs [2](#embr201949752-fig-0002){ref-type="fig"}C and [EV2](#embr201949752-fig-0002ev){ref-type="fig"}G) as well as in the expression of embryonic myosin (Fig [2](#embr201949752-fig-0002){ref-type="fig"}D) following cardiac injury, suggesting that promoting glycolysis in CMs can increase their dedifferentiation and proliferative potential. Furthermore, we examined *pkma2* ^−/−^; *pkmb* ^+/−^ animals at 60 dpci. We performed Acid Fuchsin Orange G (AFOG) staining to examine scar size. Notably, *pkma2* ^−/−^; *pkmb* ^+/−^ animals exhibited a significantly larger scar area compared to *pkma2* ^+/−^; *pkmb* ^+/−^ animals (Fig [2](#embr201949752-fig-0002){ref-type="fig"}E). However, *ppargc1a* mutants did not exhibit a significant difference in scar area (Fig [2](#embr201949752-fig-0002){ref-type="fig"}F). Together, these results provide further evidence that key regulators of pyruvate metabolism and glycolysis play an important role in CM dedifferentiation and proliferation in the early stages of cardiac regeneration.

Cardiomyocyte‐specific modulation of pyruvate metabolism regulates cardiomyocyte behavior following cardiac injury {#embr201949752-sec-0005}
------------------------------------------------------------------------------------------------------------------

Expression analysis showed that multiple *pdk* genes were highly upregulated in tissues bordering the damaged area following cardiac injury (Fig [1](#embr201949752-fig-0001){ref-type="fig"}C). Pdk promotes the conversion of pyruvate to lactate by inactivating the PDC through phosphorylation of pyruvate dehydrogenase E1 alpha 1 subunit (Pdha1), a catalytic subunit of the PDC (Korotchkina & Patel, [2001](#embr201949752-bib-0035){ref-type="ref"}; Rardin *et al*, [2009](#embr201949752-bib-0061){ref-type="ref"}; Park *et al*, [2018](#embr201949752-bib-0054){ref-type="ref"}). To impair glycolysis specifically in CMs, we used a form of Pdha1a (Pdha1aSTA), which cannot be phosphorylated by Pdk, leading to enhanced pyruvate conversion to acetyl‐CoA (Hitosugi *et al*, [2011](#embr201949752-bib-0026){ref-type="ref"}; Fan *et al*, [2014](#embr201949752-bib-0018){ref-type="ref"}; Fukuda *et al*, [2019](#embr201949752-bib-0020){ref-type="ref"}). Using the HOTcre system (Hesselson *et al*, [2009](#embr201949752-bib-0025){ref-type="ref"}), we generated a *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* line, which, when combined with the *Tg(myl7:Cre‐ERT2)* line and following tamoxifen and heat‐shock treatments, expresses *pdha1aSTA* specifically in CMs to impair glycolysis (Fig [EV3](#embr201949752-fig-0003ev){ref-type="fig"}A). Consistent with our previous results with DCA treatments, which inhibit Pdk function, the number of proliferating CMs following cardiac injury was decreased in *Tg(myl7:Cre‐ERT2); Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* animals after tamoxifen‐induced recombination and heat‐shock treatments (Figs [3](#embr201949752-fig-0003){ref-type="fig"}A and B, and [EV3](#embr201949752-fig-0003ev){ref-type="fig"}C). Conversely, in order to stimulate glycolysis in CMs, we generated a *Tg(hsp70l:LOX‐STOP‐LOXP‐pdk3b‐T2A‐mCherry*) line and found that when *pdk3b* was overexpressed in *Tg(myl7:Cre‐ERT2); Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* animals (Fig [EV3](#embr201949752-fig-0003ev){ref-type="fig"}B), the number of proliferating CMs following cardiac injury was increased (Figs [3](#embr201949752-fig-0003){ref-type="fig"}C and [EV3](#embr201949752-fig-0003ev){ref-type="fig"}D). We also examined the effects of *pdk3b* OE in non‐injured hearts and saw no significant increase in the number of proliferating CMs (Fig [EV3](#embr201949752-fig-0003ev){ref-type="fig"}E). In line with their effects on CM proliferation, *pdha1aSTA* OE in CMs led to a decrease in the number of CMs exhibiting embryonic myosin expression, while *pdk3b* OE led to an increase (Fig [3](#embr201949752-fig-0003){ref-type="fig"}D and E). Altogether, these results suggest that pyruvate metabolism as regulated by the PDK‐PDC axis plays an important role in CM dedifferentiation and proliferation following cardiac injury. We next examined whether metabolic modulation in CMs affects scar size during cardiac regeneration, and found that *pdha1aSTA* OE led to the retention of a larger scar area at 60 dpci (Fig [3](#embr201949752-fig-0003){ref-type="fig"}F), while *pdk3b* OE did not affect scar area (Fig [3](#embr201949752-fig-0003){ref-type="fig"}G). Together with the data using metabolic enzyme mutant models, these results suggest that in the early stages of cardiac regeneration, glycolysis promotes CM dedifferentiation and proliferation and that genetic manipulations to enhance glycolytic activity do not facilitate scar resolution at later stages.

![Validation of Cre‐ERT2‐mediated recombination in transgenic animals\
A, BStaining of heart sections for MF20, mCherry, and DNA (DAPI) in *Tg(myl7:Cre‐ERT2)*;*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* (A) and *Tg(myl7:Cre‐ERT2)*;*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* (B) animals with or without tamoxifen and heat‐shock treatments. TAM, tamoxifen; HS, heat shock.C, DStaining of heart sections for pHH3, MF20, and DNA (DAPI) in 5 dpci animals (*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* (C) and *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* (D) alone (control) or in combination with *Tg(myl7:Cre‐ERT2)*, all after tamoxifen and heat‐shock treatments); magnified view of area in white boxes shown in the top right corner; arrowheads point to pHH3^+^ CMs; white dashed lines outline the wound area; percentage of pHH3^+^ CMs in the border zone shown on the right (*n* = 4--5 ventricles of each genotype).EStaining of heart sections for PCNA, MEF2, and DNA (DAPI) in animals (*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* alone (control) or in combination with *Tg(myl7:Cre‐ERT2)*, all after tamoxifen and heat‐shock treatments).Data information: Error bars, s.e.m.; *P* values were calculated by two‐tailed unpaired *t*‐test. Scale bars, 50 μm in (A, B, E); 25 μm in (C, D).](EMBR-21-e49752-g007){#embr201949752-fig-0003ev}

![Cardiomyocyte‐specific modulation of pyruvate metabolism cell‐autonomously affects their dedifferentiation and proliferation following cardiac injury\
ATransgenic animals and experimental time course for data shown in (B--E).B--EImmunostaining of heart sections for PCNA and MEF2 (B, C) or N2.261 and MEF2 (D, E) in 5 dpci animals (*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* and *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* alone (control) or in combination with *Tg(myl7:Cre‐ERT2)*, all after tamoxifen and heat‐shock treatments); magnified view of area in white boxes shown below; arrowheads point to PCNA ^+^ (B, C) or N2.261^+^ (D, E) CMs; white dashed lines outline the wound area; percentage of PCNA ^+^ (B, C) or N2.261^+^ (D, E) CMs in the border zone shown on the right (*n* = 4--5 ventricles of each genotype).F, GAFOG staining of heart sections from 60 dpci animals (*Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* (F) and *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* (G) alone (control) or in combination with *Tg(myl7:Cre‐ERT2)*, all after tamoxifen and heat‐shock treatments); black dashed lines outline the scar area; scar area measured on the right (*n* = 4--5 ventricles of each genotype).Data information: Error bars, s.e.m.; *P* values were calculated by two‐tailed unpaired *t*‐test. Scale bars, 50 μm.](EMBR-21-e49752-g006){#embr201949752-fig-0003}

Modulation of pyruvate metabolism regulates primary rat neonatal cardiomyocyte cell cycle progression and behavior {#embr201949752-sec-0006}
------------------------------------------------------------------------------------------------------------------

We also tested the role of pyruvate metabolism in primary rat neonatal cardiomyocytes (RNCMs). To examine the role of pyruvate metabolism modulation in CM cell cycle progression, Ki67 expression was analyzed in RNCMs overexpressing PDHA1STA or PDK3 in growth culture medium containing 10% bovine serum as well as in non‐growth culture medium. We found that PDHA1STA OE significantly decreased the number of Ki67^+^ RNCMs in growth conditions (Fig [4](#embr201949752-fig-0004){ref-type="fig"}A), while PDK3 OE increased the number of Ki67^+^ RNCMs (Fig [4](#embr201949752-fig-0004){ref-type="fig"}B) in non‐growth conditions. PDK3 OE also led to an increase in the number of pHH3^+^ RNCMs (Fig [EV4](#embr201949752-fig-0004ev){ref-type="fig"}C). We then determined cell numbers and found that PDHA1STA OE significantly decreased the number of RNCMs (Fig [EV4](#embr201949752-fig-0004ev){ref-type="fig"}D), while PDK3 OE did not lead to obvious changes (Fig [EV4](#embr201949752-fig-0004ev){ref-type="fig"}E). Next, we investigated the role of pyruvate metabolism in an *in vitro* scratch assay which is used to examine the ability of cells to fill a wound‐like gap in a confluent cell monolayer (Cormier *et al*, [2015](#embr201949752-bib-0011){ref-type="ref"}). We first examined CM cell cycle progression in the scratch assay and found no significant differences in the number of Ki67^+^ CMs in the area close to the scratch border compared to the remote area (Fig [EV4](#embr201949752-fig-0004ev){ref-type="fig"}A and B). We then examined CM behavior and found that RNCMs close to the scratch border exhibited membrane protrusions (Fig [4](#embr201949752-fig-0004){ref-type="fig"}C). Similar observations have been reported when analyzing zebrafish and mouse regeneration models, where CMs replenish to the injured area (Itou *et al*, [2012](#embr201949752-bib-0028){ref-type="ref"}; Morikawa *et al*, [2015](#embr201949752-bib-0052){ref-type="ref"}; Tahara *et al*, [2016](#embr201949752-bib-0067){ref-type="ref"}; Marin‐Juez *et al*, [2019](#embr201949752-bib-0050){ref-type="ref"}; preprint: Aharonov *et al*, [2020](#embr201949752-bib-0001){ref-type="ref"}). We analyzed the effects of pyruvate metabolism modulation on CM behavior in the scratch assay and found that PDK3 OE led to an increase in the number of CM membrane protrusions (Figs [4](#embr201949752-fig-0004){ref-type="fig"}C and [EV4](#embr201949752-fig-0004ev){ref-type="fig"}C). To gain insight into the signaling pathways and effectors that are regulated by PDK3 OE in RNCMs, we performed transcriptomic analysis. Notably, the resulting data indicate that PDK3 OE led to increased levels of genes encoding factors which promote DNA replication and cell cycle (Figs [4](#embr201949752-fig-0004){ref-type="fig"}D--F and [EV4](#embr201949752-fig-0004ev){ref-type="fig"}F and G). Altogether, these data indicate that pyruvate metabolism regulated by PDK also promotes mammalian CM cell cycle progression and protrusive behavior.

![Pyruvate metabolism modulation affects the behavior of rat neonatal cardiomyocytes in culture\
A, BStaining for Ki67, CTNI, and DNA (DAPI) in control, PDHA1STA OE, or PDK3 OE RNCMs cultured in growth (A) or non‐growth (B) medium; arrowheads point to Ki67^+^ RNCMs; percentage of Ki67^+^ RNCMs shown on the right (*n* = 4 biological replicates for each condition).CStaining for CTNI and DNA (DAPI) in scratch assay using control, PDHA1STA OE, or PDK3 OE RNCMs immediately or at 3 days after generating the scratch; magnified view of area in white boxes shown below; arrowheads point to membrane protrusions of RNCMs; quantification of CM membrane protrusions shown on the right (*n* = 4 biological replicates for each condition).DReactome over‐representation analysis of differentially regulated genes in PDK3 OE RNCMs compared to control.E, FHeat map of gene expression for key regulators of cell cycle (E) and DNA replication (F) in PDK3 OE vs. control RNCMs.Data information: Error bars, s.e.m.; *P* values were calculated by ordinary one‐way ANOVA with Dunnett\'s multiple comparison test (A--C) or Benjamini--Hochberg correction (D). Scale bars, 20 μm.](EMBR-21-e49752-g008){#embr201949752-fig-0004}

![Ki67 immunostaining in scratch assay\
AStaining for Ki67, CTNI, and DNA (DAPI) in the scratch border and remote area; arrowheads point to Ki67^+^ RNCMs; and white dashed line marks the scratch border.BPercentage of Ki67^+^ CMs in the 200 μm region adjacent to the scratch and in a remote area (*n* = 4 biological replicates for each condition).CStaining for pHH3, CTNI, and DNA (DAPI) in control and PDK3 OE RNCMs; arrowhead points to pHH3^+^ RNCMs; percentage of pHH3^+^ RNCMs shown on the right (*n* = 4 biological replicates for each condition).D, ERelative value of RNCM numbers (*n* = 3 biological replicates for each condition).F, GGene set over‐representation analysis with KOBAS 2.0 using KEGG and Gene Ontology databases based on differentially regulated genes in PDK3 OE RNCMs compared to control.Data information: Error bars, s.e.m.; *P* values were calculated by two‐tailed unpaired *t*‐test (B--E) or Benjamini--Hochberg correction (F, G). Scale bars, 200 μm in (A); 20 μm in (C).](EMBR-21-e49752-g009){#embr201949752-fig-0004ev}

Glycolysis plays an important role in the proliferation of cancer cells (Liberti & Locasale, [2016](#embr201949752-bib-0043){ref-type="ref"}), endothelial cells (De Bock *et al*, [2013](#embr201949752-bib-0015){ref-type="ref"}; Wilhelm *et al*, [2016](#embr201949752-bib-0071){ref-type="ref"}), and neural progenitor cells (Zheng *et al*, [2016](#embr201949752-bib-0076){ref-type="ref"}), as well as during cardiac (Wang *et al*, [2018](#embr201949752-bib-0070){ref-type="ref"}; Honkoop *et al*, [2019](#embr201949752-bib-0027){ref-type="ref"}; Magadum *et al*, [2020](#embr201949752-bib-0049){ref-type="ref"}) and skeletal muscle (Wagner *et al*, [1976](#embr201949752-bib-0069){ref-type="ref"}; Magadum & Engel, [2018](#embr201949752-bib-0048){ref-type="ref"}) regeneration. Here, we showed that CM‐specific modulation of glycolysis also regulates CM dedifferentiation and proliferation during regeneration. In addition, our transcriptomic data show that PDK3 OE, which enhances glycolysis, leads to higher levels of cell cycle regulator gene expression in RNCMs. It will of course be important to investigate further how glycolysis regulates these processes.

Our data indicate that increased glycolysis by Pdk3 OE promotes CM dedifferentiation following cardiac injury. It was reported that in regenerating CMs, mitochondria exhibit an immature structure and that the levels of mitochondrial gene expression are reduced (Honkoop *et al*, [2019](#embr201949752-bib-0027){ref-type="ref"}), indicating lower mitochondrial activity. In addition, mitochondrial function increases during CM maturation in the developing heart (Menendez‐Montes *et al*, [2016](#embr201949752-bib-0051){ref-type="ref"}). Thus, reduced mitochondrial activity, and thereby reduced OXPHOS, may be important for CM dedifferentiation and proliferation during regeneration.

It has also been shown that the levels of glycolytic enzymes increase following cardiac ischemia and in failing hearts (Das *et al*, [1987](#embr201949752-bib-0014){ref-type="ref"}; Doenst *et al*, [2013](#embr201949752-bib-0017){ref-type="ref"}). However, adult mice do not exhibit robust cardiac regeneration. Recent data show that the upregulation of PKM2 levels following cardiac injury is limited and thus possibly insufficient to promote CM proliferation in an ischemic adult mouse model (Magadum *et al*, [2020](#embr201949752-bib-0049){ref-type="ref"}), while *Pkm2* OE induced CM proliferation after cardiac injury (Magadum *et al*, [2020](#embr201949752-bib-0049){ref-type="ref"}). Together, these data suggest that the levels of glycolytic gene expression in mice following cardiac injury might be a limiting factor in terms of promoting CM proliferation. It will be interesting to further investigate the differences in metabolic changes between zebrafish and mouse cardiac injury models.

During cardiac regeneration, it is assumed that newly divided CMs have to undergo maturation to generate fully functional cardiac tissue. During development, the metabolic shift from glycolysis to OXPHOS plays an important role in CM differentiation and maturation (Cho *et al*, [2006](#embr201949752-bib-0007){ref-type="ref"}; Chung *et al*, [2007](#embr201949752-bib-0009){ref-type="ref"}). Our data in zebrafish indicate that while enhanced glycolysis by Pdk3 OE promotes CM proliferation during the early stages of cardiac regeneration, scar resolution at later stages does not appear to be significantly affected. However, it remains unclear whether, in conditions of Pdk3 OE, the newly formed CMs have undergone maturation and also whether CM maturation promotes scar resolution. Clearly, many questions remain to be addressed to fully understand the role of metabolism during cardiac regeneration.

Together, our data indicate that cardiac metabolism regulated by the PDK‐PDC axis promotes CM proliferation following cardiac injury in zebrafish as well as cell cycle progression of mammalian CMs in culture.

Materials and Methods {#embr201949752-sec-0007}
=====================

Zebrafish {#embr201949752-sec-0008}
---------

All zebrafish husbandry was performed under standard conditions in accordance with FELASA guidelines (Aleström *et al*, [2019](#embr201949752-bib-0002){ref-type="ref"}) and institutional (MPG) and national ethical and animal welfare guidelines. The following transgenic lines and mutants were used: *Tg(cryaa:DsRed,‐5.1myl7:CreERT2)* ^*pd10*^ (Kikuchi *et al*, [2010](#embr201949752-bib-0030){ref-type="ref"}) abbreviated *Tg(myl7:CreERT2)*,*pkma*2^*s717*^ (Stone *et al*, [2018](#embr201949752-bib-0066){ref-type="ref"}), *pkmb* ^*s718*^ (Stone *et al*, [2018](#embr201949752-bib-0066){ref-type="ref"}), and *ppargc1a* ^*bns176*^ (Marin‐Juez *et al*, [2019](#embr201949752-bib-0050){ref-type="ref"}). To generate *Tg(cryaa:Cerulean,hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* ^*bns343*^ abbreviated *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdha1aSTA‐T2A‐mCherry)* and *Tg(cryaa:Cerulean,hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry)* ^*bns344*^ abbreviated *Tg(hsp70l:LOXP‐STOP‐LOXP‐pdk3b‐T2A‐mCherry), pdk3b* (NM_001080688) and *pdha1a* (NM_213393) were isolated by RT--PCR and cloned into a vector containing a promoter of *heat‐shock cognate 70‐kd protein, like* (*hsp70l*), and two I‐SceI restriction sites. The following primers were used to amplify the cDNA: *pdk3b* (forward 5′‐TTCCACTAGTGCTCCACCGGTCCACCATGAAACTGTTTATCTG‐3′ and reverse 5′‐GCCCTCTCCACTGCCCTCGAGTCTGTTGACTTTGTATGTGGA‐3′); *pdha1a* (forward 5′‐TTCCACTAGTGCTCCACCGGTCCACCATGAGAAAGATGC‐3′ and reverse 5′‐GCCCTCTCCACTGCCCTCGAGGCTGATGGACTTGAGTTTG‐3′). Plasmids were then injected into one‐cell‐stage embryos with I‐SceI (NEB).

Cryoinjury and quantification {#embr201949752-sec-0009}
-----------------------------

Cryoinjury was performed as previously described (González‐Rosa *et al*, [2011](#embr201949752-bib-0022){ref-type="ref"}). Confocal images were processed using the ZEN software (ZEISS), and PCNA^+^, N2.261^+^, or pHH3^+^ CMs in the 50‐μm region adjacent to the injured area at 5 dpci were counted. The percentage of PCNA^+^, N2.261^+^, or pHH3^+^ CMs in the border zone was calculated by dividing the number of PCNA^+^, N2.261^+^, or pHH3^+^ CMs by the total number of CMs.

Pharmacological treatments {#embr201949752-sec-0010}
--------------------------

Adult zebrafish were treated with PBS, 2‐DG (1 nmol/mg body weight; Sigma‐Aldrich), or DCA (0.5 nmol/mg body weight; Sigma‐Aldrich) by intraperitoneal (IP) injections (Kinkel *et al*, [2010](#embr201949752-bib-0032){ref-type="ref"}) from 1 to 4 dpci and analyzed at 5 dpci.

Tamoxifen and heat‐shock treatments {#embr201949752-sec-0011}
-----------------------------------

To induce Cre‐ERT2‐mediated recombination, animals were treated with 10 μM 4‐hydroxytamoxifen (4‐HT; Sigma‐Aldrich) by IP injection. Cryoinjury was performed 24 h after 4‐HT injection. Heat‐shock treatments were performed in a 37°C water bath for 1 h per day from 1 to 4 dpci, and animals were analyzed at 5 dpci. To examine 60 dpci hearts in transgenic animals (Fig [3](#embr201949752-fig-0003){ref-type="fig"}F and G), heat‐shock treatments were performed five to seven times a week from 1 to 59 dpci.

Staining {#embr201949752-sec-0012}
--------

Zebrafish heart sections and RNCMs were fixed in 4% paraformaldehyde. Anti‐MEF2 1:50 (sc‐313, Santa Cruz Biotechnology), anti‐PCNA 1:500 (PC10, Santa Cruz Biotechnology), anti‐N2.261 1:100 (N2.261, DSHB), anti‐DsRed 1:500 (632496, Takara), anti‐MHC 1:500 (MF20, DSHB), anti‐phospho‐histone H3 1:200 (06‐570, EMD Millipore), and anti‐cardiac troponin I (CTNI) 1:500 (ab56357, Abcam) were used. After washing with PBS, samples were stained with Alexa 568, Alexa 488, or Alexa 647 secondary antibodies 1:500 (Life Technologies), followed by 4′,6‐diamidine‐2′‐phenylindole dihydrochloride (DAPI) 1:2,000 (Merck) staining to visualize DNA. To count PCNA^+^, N2.261^+^, or pHH3^+^ CMs in regenerating ventricles, we analyzed more than three sections from each heart. Acid Fuchsin Orange G (AFOG) staining was performed using the A.F.O.G. Kit (BIOGNOST).

Cell culture {#embr201949752-sec-0013}
------------

Rat neonatal (P1--P3) CMs were isolated as previously described (Fukuda *et al*, [2017](#embr201949752-bib-0019){ref-type="ref"}), and CMs were further separated by density gradient centrifugation (Golden *et al*, [2012](#embr201949752-bib-0021){ref-type="ref"}). Cells were plated onto 0.1% gelatin‐coated (Sigma) plates and cultured in DMEM/F12 (Gibco) supplemented with 5% horse serum, [l]{.smallcaps}‐glutamine, Na pyruvate, penicillin, and streptomycin at 37°C and 5% CO~2~. 10% FBS (HyClone) was added to the medium for the growth conditions. CMs were transfected with adenovirus vectors and cultured for 72 h in growth medium or non‐growth medium. Samples were then fixed with 4% PFA and stained with anti‐CTNI and DAPI. Five different 1,000 μm regions per sample were analyzed for CM numbers, and average values were used.

Lactate measurements {#embr201949752-sec-0014}
--------------------

Lactate levels were measured using a PicoProbe Lactate Fluorometric Assay Kit (BioVision). For each condition, the cryoinjured area and adjacent tissue from 10 ventricles were collected in PBS and homogenized. Samples were centrifuged, and the supernatant was used to measure lactate levels according to manufacturer\'s protocol. Fluorescence was detected with a FLUOstar Omega instrument (BMG).

Adenovirus vectors {#embr201949752-sec-0015}
------------------

Adenovirus vectors for transfection into CMs were generated using the AdEasy system (Agilent Technologies). The adenovirus vector encoding *Pdk3* was previously described (Fukuda *et al*, [2019](#embr201949752-bib-0020){ref-type="ref"}). To amplify *Pdha1* (NM_008810) from mouse tissues, the following primers were used: *Pdha1* (forward 5′‐TAGAGATCTGGTACCGTCGACcACCATGAGGAAGATGCTTGCC‐3′ and reverse 5′‐GGATATCTTATCTAGAAGCTTAACTGACTGACTTAAACTTGATC). To generate *Pdha1STA*, the following primers were used: forward 5′‐TACCGCTACCATGGACACGCCATGAGTGACCCTGGAGTAAGCGCCCGCACTCGAGAAGAAATC‐3′ and reverse 5′‐GATTTCTTCTCGAGTGCGGGCGCTTACTCCAGGGTCACTCATGGCGTGTCCATGGTAGCGGTA‐3′

Scratch assay {#embr201949752-sec-0016}
-------------

CMs were cultured in growth medium until the plates were confluent and then transfected with adenovirus vectors encoding the gene of interest. After 24 h of culture, a sterilized plastic ruler was laid on the plate, and a sterile pipette tip was used to make a scratch in the CM layer as previously described (Cormier *et al*, [2015](#embr201949752-bib-0011){ref-type="ref"}). After removing the dead cells, the plates were incubated for 3 days and then analyzed. To quantify CM membrane protrusions in the scratch assay, the number of CM membrane protrusions in an area of 1,000 μm height × 200 μm width was determined. The average value from two different regions per sample was used. Values were normalized to the average value of control.

Imaging {#embr201949752-sec-0017}
-------

A Zeiss spinning disk confocal microscope (CSU‐X1, Yokogawa) and ORCA‐Flash4.0 sCMOS camera (Hamamatsu) were used to acquire images. Time‐lapse imaging for the scratch assay was performed using an SP8 microscope (Leica).

RT--qPCR {#embr201949752-sec-0018}
--------

The miRNeasy Mini Kit (Qiagen) was used for total RNA extraction, and cDNA was synthesized using the SuperScript Second Strand Kit (Life Technologies). The CFX Connect Real‐Time System (Bio‐Rad) and DyNAmo ColorFlash SYBR Green qPCR Kit (Thermo Fisher Scientific) were used. Technical replicates were analyzed for each sample. Primer sequences are shown in [Table EV1](#embr201949752-sup-0003){ref-type="supplementary-material"} and Ct values in [Table EV2](#embr201949752-sup-0004){ref-type="supplementary-material"}.

Statistical analysis {#embr201949752-sec-0019}
--------------------

Benjamini--Hochberg‐corrected *P* values as well as standard errors for the fold changes represented by error bars were calculated using limma for proteomic analysis (Fig [1](#embr201949752-fig-0001){ref-type="fig"}A and B). Comparative statistics between two sample groups was performed using two‐tailed unpaired *t*‐test and between more than two sample groups using ordinary one‐way ANOVA with Dunnett\'s multiple comparison test for parametric data. Benjamini--Hochberg correction was used for RNA‐seq data analysis.

Mass spectrometry {#embr201949752-sec-0020}
-----------------

Zebrafish ventricles were homogenized with a grinder in SDS lysis buffer (4% SDS in 0.1 M Tris--HCl pH 7.6) and heated at 70°C for 10 min. For DNA shearing, samples were sonicated prior to sedimentation of cell debris by centrifugation at 16,000 *g* for 10 min. Cleared supernatants were subjected to estimation of protein concentration (DC protein assay, Bio‐Rad). Protein samples were separated according to their molecular weight by SDS--PAGE (NuPAGE 4--12% Bis‐Tris Gel, Thermo Scientific), stained by InstantBlue Coomassie staining (Expedeon), and subjected to in‐gel digestion (Shevchenko *et al*, [2006](#embr201949752-bib-0065){ref-type="ref"}). Finally, samples were desalted and stored on STop And Go Extraction (STAGE) tips (Rappsilber *et al*, [2003](#embr201949752-bib-0060){ref-type="ref"}) prior to analysis by liquid chromatography--tandem mass spectrometry (LC‐MS/MS). Capillary LC was performed in line to a Q Exactive HF mass spectrometer (Thermo Scientific) via an electrospray ionization (ESI) source using a nano‐UHPLC System (EASY‐nLC 1000, Thermo Scientific), as well as an in‐house packed 70 μm ID, 15‐cm reverse‐phase column emitter (ReproSil‐Pur 120 C18‐AQ, 1.9 μm, Dr. Maisch GmbH) with a buffer system comprising solvent A (5% acetonitrile and 1% formic acid) and solvent B (80% acetonitrile and 1% formic acid). Relevant instrumentation parameters were extracted using MARMoSET (Kiweler *et al*, [2019](#embr201949752-bib-0033){ref-type="ref"}) and are included in the [Appendix](#embr201949752-sup-0001){ref-type="supplementary-material"} information. Raw data processing was done using the MaxQuant suite of algorithms (v. 1.6.8.0) (Cox & Mann, [2008](#embr201949752-bib-0012){ref-type="ref"}) against the *Danio rerio* UniProtKB database (canonical and isoforms; downloaded on 2019/08/19; 62,099 entries) with parameters documented in the supplementary material and employing label‐free quantitation (Cox *et al*, [2014](#embr201949752-bib-0013){ref-type="ref"}). Downstream bioinformatics analysis was performed using a limma‐based R pipeline (Ritchie *et al*, [2015](#embr201949752-bib-0062){ref-type="ref"}) (<https://github.com/bhagwataditya/autonomics>), on logarithmized intensities provided by MaxQuant and including an over‐representation analysis by Fisher\'s exact test, testing for enrichment of KEGG annotation terms in protein groups significantly (*P* ≤ 0.05) upregulated in 150 dpf vs. 30 dpf hearts as compared to the detectome, the total of all detected protein groups.

RNA‐seq analysis {#embr201949752-sec-0021}
----------------

Total RNA was isolated from RNCMs using the miRNeasy Mini Kit (Qiagen). RNA and library preparation integrity were verified with LabChip GX Touch 24 (Perkin Elmer). 1 μg of total RNA was used as input for VAHTS Stranded mRNA‐seq Library Preparation following manufacturer\'s protocol (Vazyme). Sequencing was performed on a NextSeq 500 instrument (Illumina) using v2 chemistry, resulting in an average of 37 M reads per library with 1 × 75 bp single‐end setup. The resulting raw reads were assessed for quality, adapter content, and duplication rates with FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc>). Trimmomatic version 0.39 was employed to trim reads after a quality drop below a mean of Q20 in a window of 5 nucleotides (Bolger *et al*, [2014](#embr201949752-bib-0006){ref-type="ref"}). Only reads between 30 and 150 nucleotides were cleared for further analyses. Trimmed and filtered reads were aligned vs. the Ensembl Rat genome version rn6 (version 94) using STAR 2.6.1d with the parameter "--outFilterMismatchNoverLmax 0.1" to increase the maximum ratio of mismatches to mapped length to 10% (STAR: ultrafast universal RNA‐seq aligner) (Dobin *et al*, [2013](#embr201949752-bib-0016){ref-type="ref"}). The number of reads aligning to genes was counted with featureCounts 1.6.5 tool from the Subread package (Liao *et al*, [2014](#embr201949752-bib-0042){ref-type="ref"}). Only reads mapping at least partially inside exons were admitted and aggregated per gene. Reads overlapping multiple genes or aligning to multiple regions were excluded. Differentially expressed genes were identified using DESeq2 version 1.26.0 (Love *et al*, [2014](#embr201949752-bib-0045){ref-type="ref"}). Only genes with a minimum fold change of ± 2 (log~2~ = ± 1), a maximum Benjamini--Hochberg‐corrected *P*‐value of 0.05, and a minimum combined mean of 5 reads were deemed to be significantly differentially expressed. The Ensembl annotation was enriched with UniProt data (release 17.12.2018) based on Ensembl gene identifiers (Activities at the Universal Protein Resource (UniProt)). Gene Ontology analyses were performed using KEGG (<https://www.genome.jp/kegg/kegg_ja.html>), Reactome (<https://reactome.org/>), and KOBAS 2.0 (Xie *et al*, [2011](#embr201949752-bib-0073){ref-type="ref"}). Two separate tests were performed per contrast using only either up‐ or down‐regulated genes for analysis. The results were combined keeping only gene sets that showed significant over‐representation at FDR \< 0.2 in only one input list (i.e., that were clearly enriched for up‐ or down‐regulated genes, but not both). The Top10 gene sets considering enrichment FDR were selected per direction of regulation. The dashed line represents an FDR of 0.05, while the values in brackets denote the number of regulated genes vs. total genes in the respective pathway (Figs [4](#embr201949752-fig-0004){ref-type="fig"}D and [EV4](#embr201949752-fig-0004ev){ref-type="fig"}F and G).
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